260 related articles for article (PubMed ID: 11766156)
41. Systemic injection of p-chloroamphetamine eliminates the effect of the 5-HT3 compounds on learning.
Hong E; Meneses A
Pharmacol Biochem Behav; 1996 Apr; 53(4):765-9. PubMed ID: 8801576
[TBL] [Abstract][Full Text] [Related]
42. Combined blockade of 5-HT3- and 5-HT4-serotonin receptors inhibits colonic functions in conscious rats and mice.
Nagakura Y; Kontoh A; Tokita K; Tomoi M; Shimomura K; Kadowaki M
J Pharmacol Exp Ther; 1997 Apr; 281(1):284-90. PubMed ID: 9103508
[TBL] [Abstract][Full Text] [Related]
43. Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on temporal differentiation: evidence for the involvement of 5-HT2A but not 5-HT3 receptors in interval timing behaviour.
Body S; Asgari K; Rickard JF; Zhang Z; Fone KC; Bradshaw CM; Szabadi E
Psychopharmacology (Berl); 2005 Sep; 181(2):289-98. PubMed ID: 15864559
[TBL] [Abstract][Full Text] [Related]
44. Effects of various 5-HT3 receptor antagonists, granisetron, ondansetron, ramosetron and azasetron on serotonin (5-HT) release from the ferret isolated ileum.
Endo T; Minami M; Kitamura N; Teramoto Y; Ogawa T; Nemoto M; Hamaue N; Hirafuji M; Yasuda E; Blower PR
Res Commun Mol Pathol Pharmacol; 1999; 104(2):145-55. PubMed ID: 10634307
[TBL] [Abstract][Full Text] [Related]
45. Peripheral nerve injury reduces analgesic effects of systemic morphine via spinal 5-hydroxytryptamine 3 receptors.
Kimura M; Obata H; Saito S
Anesthesiology; 2014 Aug; 121(2):362-71. PubMed ID: 24887968
[TBL] [Abstract][Full Text] [Related]
46. Changes in serotonin level in the hypoglossal nucleus region during carbachol-induced atonia.
Kubin L; Reignier C; Tojima H; Taguchi O; Pack AI; Davies RO
Brain Res; 1994 May; 645(1-2):291-302. PubMed ID: 7520343
[TBL] [Abstract][Full Text] [Related]
47. Serotonergic excitatory drive to hypoglossal motoneurons in the decerebrate cat.
Kubin L; Tojima H; Davies RO; Pack AI
Neurosci Lett; 1992 May; 139(2):243-8. PubMed ID: 1608554
[TBL] [Abstract][Full Text] [Related]
48. Circadian dependence of receptors that mediate wake-related excitatory drive to hypoglossal motoneurons.
Volgin DV; Stettner GM; Kubin L
Respir Physiol Neurobiol; 2013 Sep; 188(3):301-7. PubMed ID: 23665050
[TBL] [Abstract][Full Text] [Related]
49. Increased waking after intra-accumbens injection of m-chlorophenylbiguanide: prevention with serotonin or dopamine receptor antagonists.
Ponzoni A; Monti JM; Jantos H; Altier H; Monti D
Eur J Pharmacol; 1995 May; 278(2):111-5. PubMed ID: 7671995
[TBL] [Abstract][Full Text] [Related]
50. Contrasting effects of 5-HT
Pratt WE; Lin P; Pierce-Messick Z; Ilesanmi AO; Clissold KA
Behav Brain Res; 2017 Apr; 323():15-23. PubMed ID: 28115218
[TBL] [Abstract][Full Text] [Related]
51. c-Fos induction in the rostroventrolateral medulla by 5-HT3 receptor activation in the nucleus tractus solitarius.
Nosjean A; Hamon M; Laguzzi R
Neuroreport; 1998 Feb; 9(3):373-8. PubMed ID: 9512374
[TBL] [Abstract][Full Text] [Related]
52. Breathing stimulation mediated by 5-HT
Iovino L; Mutolo D; Cinelli E; Contini M; Pantaleo T; Bongianni F
Brain Res; 2019 Feb; 1704():26-39. PubMed ID: 30244021
[TBL] [Abstract][Full Text] [Related]
53. Antagonism of orexin receptors in the posterior hypothalamus reduces hypoglossal and cardiorespiratory excitation from the perifornical hypothalamus.
Stettner GM; Kubin L
J Appl Physiol (1985); 2013 Jan; 114(1):119-30. PubMed ID: 23104701
[TBL] [Abstract][Full Text] [Related]
54. Differential influence of two serotonin 5-HT3 receptor antagonists on spinal serotonin-induced analgesia in rats.
Bardin L; Jourdan D; Alloui A; Lavarenne J; Eschalier A
Brain Res; 1997 Aug; 765(2):267-72. PubMed ID: 9313899
[TBL] [Abstract][Full Text] [Related]
55. Temperature, food intake, and locomotor activity effects of a 5-HT3 receptor agonist and two 5-HT3 receptor antagonists in rats.
Mazzola-Pomietto P; Aulakh CS; Murphy DL
Psychopharmacology (Berl); 1995 Oct; 121(4):488-93. PubMed ID: 8619014
[TBL] [Abstract][Full Text] [Related]
56. Behavioral, physiological and neuroendocrine responses in healthy volunteers to m-chlorophenylpiperazine (m-CPP) with and without ondansetron pretreatment.
Broocks A; Briggs NC; Pigott TA; Hill JL; Canter SK; Tolliver TJ; Baldemore D; Murphy DL
Psychopharmacology (Berl); 1997 Mar; 130(2):91-103. PubMed ID: 9106905
[TBL] [Abstract][Full Text] [Related]
57. An electrophysiological investigation of the properties of 5-HT3 receptors of rabbit nodose ganglion neurones in culture.
Peters JA; Malone HM; Lambert JJ
Br J Pharmacol; 1993 Oct; 110(2):665-76. PubMed ID: 7694755
[TBL] [Abstract][Full Text] [Related]
58. Long-term intermittent hypoxia: reduced excitatory hypoglossal nerve output.
Veasey SC; Zhan G; Fenik P; Pratico D
Am J Respir Crit Care Med; 2004 Sep; 170(6):665-72. PubMed ID: 15229096
[TBL] [Abstract][Full Text] [Related]
59. Interaction between opiate and 5-HT3 receptor antagonists in the regulation of alcohol intake.
Le AD; Sellers EM
Alcohol Alcohol Suppl; 1994; 2():545-9. PubMed ID: 8974381
[TBL] [Abstract][Full Text] [Related]
60. Chronic intermittent hypoxia alters density of aminergic terminals and receptors in the hypoglossal motor nucleus.
Rukhadze I; Fenik VB; Benincasa KE; Price A; Kubin L
Am J Respir Crit Care Med; 2010 Nov; 182(10):1321-9. PubMed ID: 20622040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]